These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9822043)

  • 1. Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease.
    Saitta A; Sardo A; Bonaiuto M; Giordano G; Imbalzano E; Castaldo M; Cinquegrani M; D'Arrigo D; Campo GM; Squadrito F
    Angiology; 1998 Nov; 49(11):879-84. PubMed ID: 9822043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.
    Giustina A; Perini P; Desenzani P; Bossoni S; Ianniello P; Milani M; Davì G; Romanelli G
    Diabetes; 1998 Mar; 47(3):423-30. PubMed ID: 9519749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism.
    Vezza R; Spina D; Tallarida RJ; Nathan M; Page CP; Gresele P
    Thromb Haemost; 1997 Nov; 78(5):1385-91. PubMed ID: 9408024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor.
    Malini PL; Strocchi E; Zanardi M; Milani M; Ambrosioni E
    Lancet; 1997 Jul; 350(9070):15-8. PubMed ID: 9217714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytes.
    Ratti S; Quarato P; Casagrande C; Fumagalli R; Corsini A
    Eur J Pharmacol; 1998 Aug; 355(1):77-83. PubMed ID: 9754941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
    D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
    Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG; Coccheri S; Marubini E; Violi F;
    Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
    Gresele P; Deckmyn H; Arnout J; Nenci GG; Vermylen J
    Thromb Haemost; 1989 Jun; 61(3):479-84. PubMed ID: 2552606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effect of picotamide on platelet function in diabetic subjects].
    Carleo R; Veno L; Fuccio F; Bonavita M; De Matteo A; Gallo M; Gatti A; Gobbo M; Nocerino L
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):647-54. PubMed ID: 2083059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of picotamide, a dual anti-thromboxane agent, in patients with thrombocytosis and a previous thromboembolic event: a 1-year observational study.
    Pogliani E; Milani M
    J Int Med Res; 1996; 24(3):311-5. PubMed ID: 8725994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
    Neirotti M; Molaschi M; Ponzetto M; Macchione C; Poli L; Bonino F; Fabris F
    Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of arteriolar reactivity and blood coagulation parameters during picotamide treatment].
    Saitta A; Bonaiuto M; Mileto A
    Clin Ter; 1991 Oct 15-31; 139(1-2):9-16. PubMed ID: 1837769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease.
    Collins CE; Benson MJ; Burnham WR; Rampton DS
    Aliment Pharmacol Ther; 1996 Jun; 10(3):315-20. PubMed ID: 8791957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression.
    Gresele P; Corona C; Alberti P; Nenci GG
    Thromb Haemost; 1990 Aug; 64(1):80-6. PubMed ID: 2274931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of picotamide in nephropathy with mesangial IgA deposits. The effect on thromboxane generation].
    Sagripanti A; Cupisti A; Giannessi D; Baicchi U; Bernini W; de Caterina R; Barsotti G
    Clin Ter; 1993 Jan; 142(1):47-52. PubMed ID: 8472511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prolonged picotamide therapy on platelet activity in patients with peripheral arterial disease.
    Danese C; Sergio G; Giunta G; Landi MT; Renzulli C; Panciocco MG; De Rossi MG; Perego MA
    Curr Med Res Opin; 1988; 11(4):221-6. PubMed ID: 2975203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of picotamide in the reduction of cardiovascular events in diabetic patients.
    Celestini A; Violi F
    Vasc Health Risk Manag; 2007; 3(1):93-8. PubMed ID: 17583179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
    Milani M; Longoni A; Maderna M
    Br J Clin Pharmacol; 1996 Dec; 42(6):782-5. PubMed ID: 8971437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of picotamide on platelet aggregation and on thromboxane A2 production in vivo.
    Minuz P; Lechi C; Arosio E; Guzzo P; Zannoni M; Lauciello C; Lechi A
    Thromb Haemost; 1991 Mar; 65(3):312-6. PubMed ID: 2048055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure.
    Castellani S; Paniccia R; Di Serio C; La Cava G; Poggesi L; Fumagalli S; Gensini GF; Neri Serneri GG
    J Am Coll Cardiol; 2003 Jul; 42(1):133-9. PubMed ID: 12849673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.